Guselkumab maintenance dose is 100 mg sc q8wks. GUIDE ph 3b trial treated 297 PSO super responders (PASI <3) w/ q8wk or extended q16wk GUS & demonstrated noninferiority of q16 wk dosing w/ disease control (91.9 vs 92.6%) https://t.co/31DPTmcVD2 https://t.co/qHMsyYCH4J
Links:
16-Week vs 8-Week Guselkumab Dosing in Super Responders for Control of Psoriasis
https://buff.ly/4fqZmGK
Aug-02-2024
